e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Asthma analysis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma
H. Yakar (Istanbul, Turkey), E. Ceylan (Istanbul, Turkey), A. Kanbay (Istanbul, Turkey)
Source:
International Congress 2018 – Asthma analysis
Session:
Asthma analysis
Session type:
Poster Discussion
Number:
3689
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Yakar (Istanbul, Turkey), E. Ceylan (Istanbul, Turkey), A. Kanbay (Istanbul, Turkey). The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma. 3689
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Evaluation of Asthma control and oral corticosteroids in Severe Asthma
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
Prescribing Trends of Oral Corticosteroids Among Young Adults with Active Asthma
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Audit of Duration of Corticosteroid Treatment in Acute Exacerbations of COPD
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma.
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020
ERS Short Guideline: Inhaled corticosteroid withdrawal in COPD
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
Experience with omalizumab in patients with moderate and severe asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Long-acting beta2 agonist without concomitant inhaled corticosteroids in children with asthma in primary care
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Exacerbations and Eosinophil Levels in ACCESS Cohort Participants Prescribed Inhaled Triple Therapy
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Year: 2018
Efficacy and safety of indacaterol acetate on ICS background therapy in asthma
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
The Effect of Bronchial Thermoplasty on Lung Function in Severe Asthma Patients
Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction
Year: 2018
Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT
Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2018
Treatment compliance in patients with Asthma, COPD and Mixed Asthma-COPD.
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Effectiveness of Mepolizumab in Reducing Asthma Exacerbations in Japan
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Adherence with inhaled corticosteroids in asthma: Does pregnancy lead to improved adherence?
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept